Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Finance and insurance tags : Treatment save search
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
Published: 2024-01-04 (Crawled : 14:00) - globenewswire.com
SILO | $1.96 1.02% 6.6K
|
Finance and Insurance
|
| O: 0.0%
H: 7.69%
C: 4.2%
spc-15 first pharma treatment study spc-14
Silo Pharma Enters into Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD
Published: 2023-11-21 (Crawled : 13:00) - globenewswire.com
SILO | $1.96 1.02% 6.6K
|
Finance and Insurance
|
| O: 0.0%
H: 21.47%
C: 12.88%
spc-15 pharma license treatment technology agreement spc-14
Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD
Published: 2023-11-08 (Crawled : 13:00) - globenewswire.com
SILO | $1.96 1.02% 6.6K
|
Finance and Insurance
|
| O: -0.65%
H: 5.23%
C: 1.31%
spc-15 pharma treatment study spc-14
Silo Pharma Initiates Human Factor Study of SPC-15 for the Treatment of PTSD
Published: 2023-10-11 (Crawled : 13:00) - globenewswire.com
SILO | $1.96 1.02% 6.6K
|
Finance and Insurance
|
| O: -1.25%
H: 5.06%
C: 0.0%
spc-15 pharma treatment study spc-14
Silo Pharma’s SPU-21 Treatment for Autoimmune Disease Awarded U.S. Patent
Published: 2023-06-21 (Crawled : 13:00) - globenewswire.com
SILO | $1.96 1.02% 6.6K
|
Finance and Insurance
|
| O: 5.74%
H: 0.0%
C: -4.98%
spu-21 patent disease treatment
Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
Published: 2023-02-13 (Crawled : 14:00) - globenewswire.com
SILO | $1.96 1.02% 6.6K
|
Finance and Insurance
|
| O: 12.45%
H: 12.14%
C: 2.14%
treatment pharma patent alzheimer’s
UroGen Announces New Data from the OLYMPUS Trial that Shows Median Durability of Response of 28.9 Months for JELMYTO®, the Only Non-Surgical, Chemoablative Treatment for Adults with Low-Grade Upper Tra...
Published: 2022-12-02 (Crawled : 13:00) - biospace.com/
WDH | $1.23 0.0% 240K
|
Finance and Insurance
|
| O: -3.09%
H: 6.37%
C: 2.55%
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -0.55%
H: 0.64%
C: 0.09%
URGN | $14.32 0.56% 0.56% 320K
|
Health Technology
|
| O: -1.49%
H: 3.84%
C: -2.44%
SNDX | $20.44 -1.45% -1.47% 1.2M
|
Health Technology
|
| O: -0.16%
H: 1.12%
C: 0.32%
GTHX | $4.16 -2.8% -2.88% 690K
|
Health Technology
|
| O: -2.22%
H: 9.27%
C: 7.69%
ACET | $2.02 -11.01% -12.38% 930K
|
Health Technology
|
| O: -1.13%
H: 5.01%
C: 4.84%
jelmyto treatment trial response
Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for Treatment of Fibromyalgia
Published: 2022-10-10 (Crawled : 12:20) - globenewswire.com
SILO | $1.96 1.02% 6.6K
|
Finance and Insurance
|
| O: -4.75%
H: 7.38%
C: 6.09%
treatment ketamine pharma fibromyalgia study
Innovation in Waste Treatment Technology Has Become a Sustainable Alternative for Handling Bio-Hazardous Waste
Published: 2022-02-03 (Crawled : 15:30) - prnewswire.com
ARIS 4 | $13.45 -0.22% 0.0% 250K
|
|
| O: -1.39%
H: 6.65%
C: 1.16%
VKIN 4 | $0.807 -23.79% 700K
|
Finance and Insurance
|
| O: 0.0%
H: 8.77%
C: -3.51%
HCCI | $45.51 0.09% 0.1% 0
|
Industrial Services
|
| O: -0.81%
H: 1.28%
C: -1.45%
CWST | $92.45 0.0% 230K
|
Industrial Services
|
| O: -0.31%
H: 0.85%
C: 0.14%
treatment technology alternative
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.